| 1. | The 5 - year survival rate for all stages is less than 15 %
各分期总体五年存活率不到15 % 。 |
| 2. | The five - year survival rate is only about fifteen percent
（肺癌病人的） 5年存活率仅有百分之十五。 |
| 3. | Filipinos have the second poorest five - year survival rates for colon and rectal cancers of all u . s . ethnic groups
菲律宾裔在所有美国裔族群中，有次差的结肠和直肠癌5年存活率。 |
| 4. | Its clinical course differs from conventional fibrosarcoma , the prognosis is usually good and the 5 - year survival rate can be more than 80 %
它和一般的纤维瘤不一样在于它的临床表现：预后通常很好， 5年存活率可以到达80 %以上。 |
| 5. | Median surial was 13 . 7 months in the combination group and 10 . 5 months in the group gien radiotherapy alone . corresponding 5 - year surial rates were 14 . 7 % and 5 . 4 %
联合治疗组的中位生存值为13 . 7月，单独放疗组的中位生存值为10 . 5月。两组患者对应的5年存活率分别是14 . 7 %和5 . 4 % 。 |
| 6. | Ha is in the process of compiling the five - year survival rates of selected cancers by matching cases of individual cancer patients with the information of the death registry for the period between 1996 and 2001
医管局现正把一九九六年至二一年期间的个别癌症病人个案与死亡登记处的资料核对，藉以编制个别选定癌症的五年存活率。 |
| 7. | As revealed in the recent published literature , stage i lung cancer has the best result after surgery , with five year survival rate around 50 - 75 % , followed by 30 - 50 % in stage and 5 - 25 % left in stage lung cancer
当前医学文献显示第一期非小细胞肺癌病人的手术预后最好，其五年存活率约在50 - 75 %之间，第二期则为30 - 50 % ，第三期则仅剩5 - 25 % 。 |
| 8. | Patients survived a median 11 . 1 months after the diagnosis of brain metastases and a median 9 . 4 months from first srs treatment , the researchers note . one - year survival was 47 . 7 % and 2 - year survival was 17 . 7 %
研究者说，诊断脑转移后的患者平均存活时间是11 . 1月，接受一次srs治疗的患者平均存活时间是9 . 4月。一年存活率是47 . 7 % ，二年存活率是17 . 7 % 。 |
| 9. | Chemotherapy can kill the micrometastasis of osteosarcoma in lung , increase the 5 - year survival rate and provide a safe verge for limb salvage , thus help many patients to reserve their limb and improve their quality of life . the chemotherapy - resistant give a new challenge for treating osteosarcoma , but nothing can substitute chemotherapy in treating osteosarcoma
化疗可杀灭骨肉瘤肺部微转移灶,提高5年存活率,并为保肢提供一个安全的边界,使许多患者得以保存肢体,提高患者生存质量;化疗耐药的出现对骨肉瘤化疗提出了新挑战,但化疗在骨肉瘤治疗中的地位尚无法替代。 |
